Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?

被引:26
|
作者
Reichman, David E. [1 ]
Chung, Pak [1 ]
Meyer, Laura [1 ]
Greenwood, Eleni [2 ]
Davis, Owen [1 ]
Rosenwaks, Zev [1 ]
机构
[1] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY 10021 USA
关键词
IVF; consecutive cycles; time interval; OVARIAN HYPERSTIMULATION SYNDROME; GNRH ANTAGONIST; LUTEAL SUPPORT; STIMULATION; PROTOCOL; AGONIST; TRIGGER;
D O I
10.1016/j.fertnstert.2012.11.044
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether patients who failed an in vitro fertilization (IVF) cycle can proceed with a subsequent IVF cycle after waiting only one menstrual cycle, or whether there is a benefit to allowing two or more menstrual cycles to elapse before proceeding. Design: Retrospective cohort study. Setting: Academic medical center. Patient(s): All patients undergoing IVF cycles at The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, from January 1, 2002 to November 1, 2011, in whom two consecutive gonadotropin-releasing hormone (GnRH)-antagonist IVF cycles with identical stimulation protocols took place 35-140 days apart, excluding patients in whom the first cycle resulted in a clinical pregnancy. Intervention(s): None. Main Outcome Measure(s): IVF outcomes were compared for 164 patients who initiated a cycle after waiting only one menstrual cycle (35-55 days from previous oocyte retrieval) versus 557 patients waiting two or more menstrual cycles (56-140 days) from their last retrieval before proceeding with their successive cycle start, stratifying for age. Result(s): No differences were detected regarding E-2 response, oocyte yield, fertilization, or embryo development when comparing patients waiting only one cycle with those waiting two or more cycles, nor were those parameters different when comparing patients' index cycles with their immediate preceding failed cycles. Moreover, clinical outcomes regarding clinical pregnancy, live birth, and cycle cancellation were similar between both study groups. Conclusion(s): Delaying successive IVF cycle start for two or more menstrual cycles likely offers no advantage over pursuing repeated IVF after one menstrual cycle. (Fertil Steril (R) 2013; 99:1277-82. (C) 2013 by American Society for Reproductive Medicine.)
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 50 条
  • [1] Does the time interval between antimullerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study
    Polyzos, Nikolaos P.
    Nelson, Scott M.
    Stoop, Dominic
    Nwoye, Milie
    Humaidan, Peter
    Anckaert, Ellen
    Devroey, Paul
    Tournaye, Herman
    FERTILITY AND STERILITY, 2013, 100 (02) : 438 - 444
  • [2] Pretreatment with estrogen does not affect in vitro fertilization cycle outcomes in gonadotropin releasing hormone antagonist protocols
    Cedrin-Durnerin, I.
    Guivarch, A.
    Hugues, J. N.
    Bstandig, B.
    Parneix, I.
    Vasseur, C.
    Dubourdieu, S.
    Colombel, A.
    HUMAN REPRODUCTION, 2011, 26 : I47 - I47
  • [3] Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome
    Segal, Shimon
    Glatstein, Isaac
    McShane, Patricia
    Hotamisligil, Selen
    Ezcurra, Diego
    Carson, Ronald
    FERTILITY AND STERILITY, 2009, 91 (05) : 1755 - 1759
  • [4] In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle
    Kummer, Nicole E.
    Weitzman, Vanessa N.
    Benadiva, Claudio A.
    Schmidt, David W.
    Engmann, Lawrence L.
    Nulsen, John C.
    FERTILITY AND STERILITY, 2011, 95 (08) : 2592 - 2594
  • [5] Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome
    Bosch, E
    Valencia, W
    Escudero, E
    Crespo, J
    Simón, C
    Remohi, J
    Pellicer, A
    FERTILITY AND STERILITY, 2003, 80 (06) : 1444 - 1449
  • [6] Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes
    Kerimoglu, Ozlem Secilmis
    Ercan, Cihangir Mutlu
    Keskin, Ugur
    Korkmaz, Cem
    Duru, Namik Kemal
    Ergun, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (03) : 691 - 695
  • [7] Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
    Rashidi, Batool Hosein
    Kabodmehri, Roya
    Shariat, Mamak
    Tehraninejad, Ensieh Shahrokh
    Abdollahi, Alireza
    Bagheri, Maryam
    Hagholahi, Fedieh
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2019, 17 (03) : 209 - 216
  • [8] Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial
    Kolibianakis, Efstratios M.
    Venetis, Christos A.
    Kalogeropoulou, Lydia
    Papanikolaou, Evangelos
    Tarlatzis, Basil C.
    FERTILITY AND STERILITY, 2011, 95 (02) : 558 - 562
  • [9] Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles
    Reichman, David E.
    Zakarin, Lauren
    Chao, Kenny
    Meyer, Laura
    Davis, Owen K.
    Rosenwaks, Zev
    FERTILITY AND STERILITY, 2014, 102 (01) : 99 - 102
  • [10] In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols
    Farhi, Jacob
    Ben-Haroush, Avi
    Lande, Yehezkel
    Sapir, Onit
    Pinkas, Haim
    Fisch, Benjamin
    FERTILITY AND STERILITY, 2009, 91 (02) : 377 - 382